Related Experiment Videos
Successful treatment of juvenile chronic granulocytic leukemia with marrow transplantation
Insights
A young boy with juvenile chronic granulocytic leukemia achieved a complete remission after intensive chemotherapy, total body irradiation, and a bone marrow transplant. This successful leukemia treatment highlights the potential of transplantation for eligible patients.
Area of Science:
- Pediatric Oncology
- Hematology
- Stem Cell Transplantation
Background:
- Juvenile chronic granulocytic leukemia (JCGL) is a rare and aggressive hematologic malignancy in children.
- Intensive treatment regimens are often required for JCGL, but long-term outcomes can be challenging.
- Allogeneic stem cell transplantation is a potential curative option for certain hematologic malignancies.
Observation:
- A 46-month-old boy diagnosed with juvenile chronic granulocytic leukemia underwent intensive pre-transplant conditioning.
- Conditioning regimen included hydroxyurea, dimethyl myleran, cyclophosphamide, and total body irradiation.
- The patient received a bone marrow transplant from a human leukocyte antigen (HLA)-matched sibling donor.
Findings:
- The patient achieved a hematologically normal status post-transplantation.
- The patient remained disease-free for 32 months after the bone marrow transplant.
- No maintenance therapy was required to sustain remission.
Implications:
- This case demonstrates the potential efficacy of allogeneic bone marrow transplantation in treating juvenile chronic granulocytic leukemia.
- Consideration of HLA-matched sibling bone marrow transplantation should be extended to all eligible patients with JCGL.
- Successful BMT offers a curative pathway for pediatric patients with otherwise refractory hematologic malignancies.
Abstract:
A 46-month-old boy with juvenile chronic granulocytic leukemia was treated intensively with hydroxyurea, dimethyl myleran, cyclophosphamide, and total body irradiation. He then received a marrow transplant from an HL-A matched brother. Thirty-two months after the transplantation, he is hematologically normal and remains disease free on no-maintenance therapy. The successful outcome of this case suggests that a bone marrow transplant for any patient with a suitable histocompatible donor should be considered in the treatment of this disease.